Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 371

    1.

    Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group.

    Edelman JM, Turpin JA, Bronsky EA, Grossman J, Kemp JP, Ghannam AF, DeLucca PT, Gormley GJ, Pearlman DS.

    Ann Intern Med. 2000 Jan 18;132(2):97-104.PMID: 10644288 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.

    Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, Dockhorn R, Kundu S, Zhang J, Seidenberg BC, Reiss TF.

    N Engl J Med. 1998 Jul 16;339(3):147-52.PMID: 9664090 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge.

    Storms W, Chervinsky P, Ghannam AF, Bird S, Hustad CM, Edelman JM; Challenge-Rescue Study Group.

    Respir Med. 2004 Nov;98(11):1051-62.PMID: 15526805 [PubMed - indexed for MEDLINE]Related articles

    4.

    Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast.

    Pearlman DS, van Adelsberg J, Philip G, Tilles SA, Busse W, Hendeles L, Loeys T, Dass SB, Reiss TF.

    Ann Allergy Asthma Immunol. 2006 Jul;97(1):98-104.PMID: 16892789 [PubMed - indexed for MEDLINE]Related articles

    5.

    Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.

    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP, Haahtela T, Holgate ST, Picado C, Menten J, Dass SB, Leff JA, Polos PG.

    BMJ. 2003 Oct 18;327(7420):891.PMID: 14563743 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group.

    Villaran C, O'Neill SJ, Helbling A, van Noord JA, Lee TH, Chuchalin AG, Langley SJ, Gunawardena KA, Suskovic S, Laurenzi M, Jasan J, Menten J, Leff JA.

    J Allergy Clin Immunol. 1999 Sep;104(3 Pt 1):547-53.PMID: 10482826 [PubMed - indexed for MEDLINE]Related articles

    7.

    Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.

    Fish JE, Israel E, Murray JJ, Emmett A, Boone R, Yancey SW, Rickard KA.

    Chest. 2001 Aug;120(2):423-30.PMID: 11502639 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval.

    Bronsky EA, Kemp JP, Zhang J, Guerreiro D, Reiss TF.

    Clin Pharmacol Ther. 1997 Nov;62(5):556-61.PMID: 9390112 [PubMed - indexed for MEDLINE]Related articles

    9.

    Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.

    Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Piñeiro A, Wei LX, Seidenberg BC, Reiss TF.

    Ann Intern Med. 1999 Mar 16;130(6):487-95.PMID: 10075616 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstriction.

    Philip G, Pearlman DS, Villarán C, Legrand C, Loeys T, Langdon RB, Reiss TF.

    Chest. 2007 Sep;132(3):875-83. Epub 2007 Jun 15.PMID: 17573489 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.

    Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM, Edelman JM.

    Ann Allergy Asthma Immunol. 2004 Jun;92(6):641-8.PMID: 15237766 [PubMed - indexed for MEDLINE]Related articles

    12.

    Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).

    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.

    Respir Med. 2000 Jun;94(6):612-21.PMID: 10921768 [PubMed - indexed for MEDLINE]Related articles

    13.

    [The effect of montelukast, a leukotriene antagonist, on improvement of exercise-induced bronchoconstriction]

    Sun TY, Guo YF, Xu XM, Zhang HS, Hou J, Ke HX, Li YM, Fang BM, Ming SH.

    Zhonghua Jie He He Hu Xi Za Zhi. 2005 Feb;28(2):83-7. Chinese. PMID: 15854387 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.

    Rosenthal RR, Busse WW, Kemp JP, Baker JW, Kalberg C, Emmett A, Rickard KA.

    Chest. 1999 Sep;116(3):595-602.PMID: 10492259 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma.

    Kemp JP, Dockhorn RJ, Shapiro GG, Nguyen HH, Reiss TF, Seidenberg BC, Knorr B.

    J Pediatr. 1998 Sep;133(3):424-8.PMID: 9738728 [PubMed - indexed for MEDLINE]Related articles

    16.

    Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast.

    Philip G, Villarán C, Pearlman DS, Loeys T, Dass SB, Reiss TF.

    J Asthma. 2007 Apr;44(3):213-7.PMID: 17454341 [PubMed - indexed for MEDLINE]Related articles

    17.

    Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

    Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

    Pediatrics. 2001 Sep;108(3):E48.PMID: 11533366 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.

    Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB.

    Arch Intern Med. 1998 Jun 8;158(11):1213-20.PMID: 9625400 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.

    Busse W, Nelson H, Wolfe J, Kalberg C, Yancey SW, Rickard KA.

    J Allergy Clin Immunol. 1999 Jun;103(6):1075-80.PMID: 10359889 [PubMed - indexed for MEDLINE]Related articles

    20.

    Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist.

    Reiss TF, Hill JB, Harman E, Zhang J, Tanaka WK, Bronsky E, Guerreiro D, Hendeles L.

    Thorax. 1997 Dec;52(12):1030-5.PMID: 9516894 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data